Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of 131 I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen
Author:
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22986/fullpdf
Reference36 articles.
1. The international neuroblastoma risk group (INRG) classification system: An INRG task force report;Cohn;J Clin Oncol,2009
2. Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma;Kaneko;J Pediatr Hematol Oncol,1999
3. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999
4. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol;Valteau-Couanet;J Clin Oncol,2005
5. High-dose rapid schedule chemotherapy for disseminated neuroblastoma;Pearson;Eur J Cancer,1992
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma;EJC Paediatric Oncology;2024-06
2. Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma;Biochemical Pharmacology;2023-10
3. Nuclear Medicine and Cancer Theragnostics: Basic Concepts;Diagnostics;2023-09-26
4. Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine;Cancers;2022-10-21
5. Bispecific antibodies for the treatment of neuroblastoma;Pharmacology & Therapeutics;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3